Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine for older adults in South Korea
South Korea’s National Immunization Program administers the quadrivalent influenza vaccine (QIV) to manage seasonal influenza, with a particular focus on the elderly. After reviewing the safety and immune response triggered by the adjuvanted QIV (aQIV) in individuals aged 65 and older, the Ministry...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis Group
2024-12-01
|
| Collection: | Human Vaccines & Immunotherapeutics |
| Sujets: | |
| Accès en ligne: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2348124 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|